Orexin A0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Orexin A — research data
Half-life~30 minutes. Limited bioavailability via non-intranasal routes.
Regulatory statusNot FDA-approved
NCAA D1Not listed
Overview
About Orexin A
Mechanism of action
Endogenous neuropeptide produced in hypothalamus; binds OX1R and OX2R; promotes wakefulness and arousal; regulates energy homeostasis, appetite, and reward pathways.
Safety profile
Limited human data. Potential: anxiety, appetite changes, cardiovascular effects. Intranasal generally well-tolerated in studies. · Endogenous neuropeptide; limited human data; cardiovascular effects in animals; no proven major harms
Related pages